Your browser doesn't support javascript.
loading
Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial.
Minhas, Jatinder S; Wang, Xia; Lindley, Richard I; Delcourt, Candice; Song, Lili; Woodward, Mark; Lee, Tsong-Hai; Broderick, Joseph P; Pontes-Neto, Octavio M; Kim, Jong S; Ricci, Stefano; Lavados, Pablo M; Bath, Philip M; Durham, Alice C; Wang, Ji-Guang; Sharma, Vijay K; Demchuk, Andrew M; Martins, Sheila O; Chalmers, John; Anderson, Craig S; Robinson, Thompson G.
Afiliação
  • Minhas JS; Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Wang X; Faculty of Medicine, The George Institute for Global Health, University of New South Wales.
  • Lindley RI; Faculty of Medicine, The George Institute for Global Health, University of New South Wales.
  • Delcourt C; Westmead Applied Research Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Song L; Faculty of Medicine, The George Institute for Global Health, University of New South Wales.
  • Woodward M; Faculty of Medicine, The George Institute for Global Health, University of New South Wales.
  • Lee TH; Faculty of Medicine, The George Institute for Global Health, University of New South Wales.
  • Broderick JP; The George Institute for Global Health, University of Oxford, Oxford, UK.
  • Pontes-Neto OM; Department of Epidemiology, John Hopkins University, Baltimore, Maryland, USA.
  • Kim JS; Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Ricci S; Department of Neurology and Rehabilitation Medicine, University of Cincinnati Gardner Neuroscience Institute, University of Cincinnati, Cincinnati, Ohio, USA.
  • Lavados PM; Stroke Service, Neurology Division, Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Bath PM; Department of Neurology, Asan Medical Center, University of Ulsan, Seoul, South Korea.
  • Durham AC; Uo Neurologia, Unità Sanitaria Locale Umbria 1, Sedi di Citta di Castello e Branca, Trento, Italy.
  • Wang JG; Departamento de Desarrollo Académico e Investigación, Unidad de Investigación y Ensayos Clínicos, Clínica Alemana, Universidad del Desarrollo, Concepción, Chile.
  • Sharma VK; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham.
  • Demchuk AM; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Martins SO; Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Chalmers J; The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, PR China.
  • Anderson CS; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Robinson TG; Calgary Stroke Program, Departments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
J Hypertens ; 39(2): 280-285, 2021 02 01.
Article em En | MEDLINE | ID: mdl-33031175

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Hypertens Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Hypertens Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido